Untch, M., Jackisch, C., Schneeweiss, A., Conrad, B., Aktas, B., Denkert, C., Eidtmann, H., Wiebringhaus, H., Kümmel, S., Hilfrich, J., Warm, M., Paepke, S., Just, M., Hanusch, C., Hackmann, J., Blohmer, J., Clemens, M., Darb-Esfahani, S., Schmitt, W. D., Dan Costa, S., Gerber, B., Engels, K., Nekljudova, V., Loibl, S., von Minckwitz, G., , , & , (n.d.). nab-paclitaxel versus solvent-based paclitaxel in neoadjuvant chemotherapy for early breast cancer (GeparSepto—GBG 69): a randomised, phase 3 trial. Lancet oncology, 17(3), 345–356. http://access.bl.uk/ark:/81055/vdc_100030783713.0x00003a